Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-24 @ 4:49 PM
NCT ID:
NCT05638750
Eligibility Criteria:
Inclusion Criteria:
* SMA (Type I, II or III) diagnosis;
* Receives genetic based therapy;
* Aged 6 months to less than 6 years old;
* Able to participate in weekly therapy at Holland Bloorview (i.e., can attend in-person sessions);
* Able to bring appropriate respiratory equipment to weekly therapy sessions, if required;
* Substitute decision makers (SDMs) must be able to speak and read English;
* Child participant must be able to understand/follow directions in English, as age appropriate;
* SDMs must consent to participate on behalf of their child.
Exclusion Criteria:
* Live outside of Ontario;
* Tracheostomy or use of daytime ventilation (excluding ventilation used during naps).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
6 Years
Study:
NCT05638750
Study Brief:
Protocol Section:
NCT05638750